ENGLISH

 
 
您所在的位置: > 首 页 > 新闻动态

美国Merk公司资深研究员伍维思应邀来我院交流访问


作者:admin 来源: 日期:2016-12-22 12:25:50 人气:158 

20161215日下午,美国Merk公司资深研究员伍维思应放医学院院长柴之芳院士邀请来我院访问交流。伍维思研究员在PET/SPECT分子影像和探针研究方面有丰富经验。交流会由高明远教授主持。


伍维思研究员给大家做了题为“Molecular Imaging as a Powerful Tool”的精彩学术报告,他用生动的语言和形象的动画给大家展示了分子影像探针在医药领域的广泛应用。他的报告引起了师生的强烈兴趣,大家就报告内容及下一步合作展开了热烈的讨论。

报告结束后,高明远教授陪同伍维思研究员一行参观了学院的实验平台,重点介绍了分子影像与核医学研究中心的研究工作。

伍维思研究员简介:

EDUCATION

PhD, Bio-organic/ Radio Chemistry, 1987, State University of New York at Stony Brook, NY, USA

BSc, Chemistry,1982, Fudan University, Shanghai, China

MOLECULAR BIOMEDICAL IMAGING EXPERT with extensive PET/SPECT molecularbiomedical imaging / biomarker research experience. Founding member ofworldwide pharmaceutical industry’s first R&D imaging team and a member ofMRL Key R&D Awards Club. Broad spectrum expertise spans radiochemistry,biomarker, innovative imaging study design and project co-ordination, dataanalyses and interpretation. Accomplishments include worldwide / US drugregulatory submissions, 14 patents / applications, 45 refereed publications,and 57 presentations / abstracts. Proven track record of devising elegantsolutions for biomarker R&D and molecular biomedical imaging forpersonalized medicine.

Principal Consultant (Biomedical Imaging / Chemistry),CRD COMMERCE, LLC, 2009 – Current

Provided scientific / business advices to clients(including Metronics, GE, Lilly, Eisai, ABT, academics and NIH), concerningradiochemistry/biomarker R&D and applications of biomedical imaging forpharmaceutical / medical research. Initiated innovative research directions,drafted / reviewed clients’ proposals, and designed / co-ordinatedmultidisciplinary programs for clients’ pre-clinical / clinical pharmaceutical/ medical R&D.

VP for Research / Intellectual Property Management,EVERNU TECHNOLOGY, 2009 – Current

Provided scientific / business expertise, initiatedinnovative research directions, drafted proposals (for federal grants andoutside contracts / funding), served as Co-PI and managed federally fundedR&D projects; managed company’s intellectual properties as a Registered USPatent Agent.

(放射医学与防护学院)